China Grand Pharmaceutical and Healthcare Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Grand Pharmaceutical and Healthcare Holdings Limited with three other
companies in this sector in HONG KONG :
Tianjin Development Holdings Limited
sales of 3.75 billion Hong Kong Dollars [US$482.32 million]
of which 38%
CK Life Sciences Intl (Holdings) Inc
(4.94 billion Hong Kong Dollars [US$636.35 million]
China Isotope & Radiation Corp
(4.81 billion Hong Kong Dollars [US$619.91 million]
of which 70%
During the year ended December of 2020, sales at
China Grand Pharmaceutical and Healthcare Holdings Limited were HK$6.35 billion (US$817.94 million).
decrease of 3.6%
versus 2019, when the company's sales were HK$6.59 billion.
Contributing to the drop in overall sales was the 4.4% decline
in Manufacturing and Sales of Pharmaceutical , from HK$4.27 billion to HK$4.08 billion.
There were also decreases in sales in
Sales of Bio-Technology Products and Nut (down 3.5% to HK$1.50 billion)
However, these declines were partially offset by the increase in sales of
Sales of Specialised Pharmaceutical Raw (up 0.4% to HK$768.09 million)